Literature DB >> 32222346

Corrigendum to "Traditional Chinese medicine for COVID-19 treatment" [Pharmacol. Res. 155 (2020) 104743].

Jun-Ling Ren1, Ai-Hua Zhang1, Xi-Jun Wang2.   

Abstract

Entities:  

Year:  2020        PMID: 32222346      PMCID: PMC7270570          DOI: 10.1016/j.phrs.2020.104768

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


× No keyword cloud information.
The authors have informed the Journal that in the letter to the Editor referenced above there were some imprecisions that need correction as follows: the sentence “As the serious illness, combined with the patient's performance of damp-heat syndrome, and the heat is more serious than damp, QPD was added for treatment’ should have been ‘As the serious illness, combined with the patient's performance of damp-heat syndrome, and the heat became more serious than damp, QJD (Qingjin Jianghuo Decoction) was added for treatment” Legend to Fig 1 is modified as follows: Comparison of chest CT results of patients. (a), chest CT on January 24; (b), chest CT on January 28; (c), chest CT on January 30; (d), chest CT on February 4 (reproduced from Reference 7, with permission). Acknowledgments are modified as follows: We are grateful for Ms. Yinxing Zhu for providing the CT scans. The authors apologise for any inconvenience these mistakes may have caused to the readers. Editorial note: The Editor has checked the originals of the CT scans and confirms that they are authentic. It was entirely transparent to the journal throughout the editorial process that the authors were not claiming any credit for the content from reference 7. The authors of the CT scans have confirmed their permission for re-publication.
  36 in total

1.  Establishment and validation of a drug-target microarray for SARS-CoV-2.

Authors:  Peng Chen; Zehua Zeng; Hongwu Du
Journal:  Biochem Biophys Res Commun       Date:  2020-07-21       Impact factor: 3.575

Review 2.  Antiviral mechanisms of candidate chemical medicines and traditional Chinese medicines for SARS-CoV-2 infection.

Authors:  Chang Li; Lin Wang; Linzhu Ren
Journal:  Virus Res       Date:  2020-06-24       Impact factor: 3.303

3.  Databases for facilitating mechanistic investigations of traditional Chinese medicines against COVID-19.

Authors:  Sida Jiang; Qiuji Cui; Bingwei Ni; Yingying Chen; Ying Tan; Weiping Chen; Yu Zong Chen
Journal:  Pharmacol Res       Date:  2020-06-02       Impact factor: 7.658

4.  The database-based strategy may overstate the potential effects of traditional Chinese medicine against COVID-19.

Authors:  Yu-Xi Huang; Wen-Xiao Wang; Sai Zhang; Yu-Ping Tang; Shi-Jun Yue
Journal:  Pharmacol Res       Date:  2020-06-23       Impact factor: 7.658

5.  Comparative retrospective open-label study of ayurvedic medicines and their combination with allopathic drugs on asymptomatic and mildly-symptomatic COVID-19 patients.

Authors:  Acharya Balkrishna; Aarti Ben Bhatt; Pratima Singh; Swati Haldar; Anurag Varshney
Journal:  J Herb Med       Date:  2021-05-21       Impact factor: 3.032

6.  Analysis on the current quality standards of Chinese materia Medica used in COVID-19 prevention and treatment.

Authors:  Yan-Hong Shi; Yu-Feng Huang; Wang-Ying Wang; Li Yang; Hua Zhou; Zhen Sang
Journal:  Pharmacol Res       Date:  2020-07-09       Impact factor: 7.658

Review 7.  Chinese medical drugs for coronavirus disease 2019: A systematic review and meta-analysis.

Authors:  Wentai Pang; Zhi Liu; Nan Li; Yuyun Li; Fengwen Yang; Bo Pang; Xinyao Jin; Wenke Zheng; Junhua Zhang
Journal:  Integr Med Res       Date:  2020-07-28

Review 8.  Potential treatment methods targeting 2019-nCoV infection.

Authors:  Lu Zheng; Lina Zhang; Jiamin Huang; Kutty Selva Nandakumar; Shuwen Liu; Kui Cheng
Journal:  Eur J Med Chem       Date:  2020-07-28       Impact factor: 6.514

Review 9.  Chinese Therapeutic Strategy for Fighting COVID-19 and Potential Small-Molecule Inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).

Authors:  Namrta Choudhry; Xin Zhao; Dan Xu; Mark Zanin; Weisan Chen; Zifeng Yang; Jianxin Chen
Journal:  J Med Chem       Date:  2020-09-11       Impact factor: 7.446

10.  Application of a Non-Linear multi-model Ayurveda Intervention in elderly COVID-19 patients- a retrospective case series.

Authors:  K S Dinesh; P K Nazeema; Madhavi Archana; K Jayakrishnan; A S Santhi Krishna; S Swapna Chitra; V K Sujitha; Anju Sathian; M Girish Babu; Geethu Balakrishnan; C Krishnendhu
Journal:  J Ayurveda Integr Med       Date:  2021-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.